Viewing Study NCT06632093


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2025-12-27 @ 3:14 AM
Study NCT ID: NCT06632093
Status: RECRUITING
Last Update Posted: 2024-10-08
First Post: 2024-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
Sponsor: First Hospital of China Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module